|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$107M
|
–
|
–
|
–
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$79.3M
|
+$31.5M
|
+3,703,703
|
+98%
|
|
|
3
|
Carlyle Group
Washington,
District of Columbia
|
$37.1M
|
–
|
–
|
–
|
|
|
4
|
|
$33.6M
|
-$66.8K
|
-7,864
|
-0.2%
|
|
|
5
|
Takeda Pharmaceutical Company
Tokyo,
Japan
|
$33.5M
|
-$36.6M
|
-4,306,069
|
-58%
|
|
|
6
|
|
$29.2M
|
+$565K
|
+66,489
|
+2%
|
|
|
7
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$24.2M
|
–
|
–
|
–
|
|
|
8
|
Vanguard Group
Malvern,
Pennsylvania
|
$21M
|
+$193K
|
+22,684
|
+1%
|
|
|
9
|
NEA Management Company
Timonium,
Maryland
|
$20.8M
|
–
|
–
|
–
|
|
|
10
|
Avidity Partners Management
Dallas,
Texas
|
$18.4M
|
+$114K
|
+13,420
|
+0.8%
|
|
|
11
|
683 Capital Management
New York
|
$17.5M
|
+$3.14M
|
+370,000
|
+29%
|
|
|
12
|
Jennison Associates
New York
|
$17.5M
|
+$14M
|
+1,647,697
|
New
|
|
|
13
|
Gilder Gagnon Howe & Co
New York
|
$10.8M
|
-$3.72M
|
-437,515
|
-30%
|
|
|
14
|
Propel Bio Management
Los Angeles,
California
|
$9.24M
|
+$3.63M
|
+426,880
|
+96%
|
|
|
15
|
Decheng Capital
Menlo Park,
California
|
$9.03M
|
–
|
–
|
–
|
|
|
16
|
Geode Capital Management
Boston,
Massachusetts
|
$7.98M
|
+$137K
|
+16,106
|
+2%
|
|
|
17
|
Catalys Pacific
Tokyo,
Japan
|
$7.67M
|
–
|
–
|
–
|
|
|
18
|
State Street
Boston,
Massachusetts
|
$7.62M
|
+$249K
|
+29,364
|
+4%
|
|
|
19
|
Kennedy Capital Management
St Louis,
Missouri
|
$6.08M
|
+$3.06K
|
+360
|
+0.1%
|
|
|
20
|
GW&K Investment Management
Boston,
Massachusetts
|
$6.03M
|
+$55.5K
|
+6,536
|
+1%
|
|
|
21
|
Woodline Partners
San Francisco,
California
|
$6.02M
|
-$4.5M
|
-529,682
|
-48%
|
|
|
22
|
Simplify Asset Management
Las Vegas,
Nevada
|
$5.54M
|
+$2.41M
|
+284,000
|
+119%
|
|
|
23
|
Saturn V Capital Management
Austin,
Texas
|
$5.32M
|
+$2.9M
|
+340,912
|
+213%
|
|
|
24
|
Ghost Tree Capital
New York
|
$5.15M
|
+$847K
|
+99,759
|
+26%
|
|
|
25
|
Two Sigma Investments
New York
|
$4.96M
|
+$1.7M
|
+200,591
|
+75%
|
|
